Goodwill and Other Intangible Assets |
12 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Intangible Assets Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||
| Goodwill and Other Intangible Assets |
Note 7 – Goodwill and Other Intangible Assets
The following table provides the gross and net carrying value of goodwill as follows:
The Company completed its annual impairment test for goodwill during the fourth quarter of 2024, which resulted in full impairment of the Company’s $1,336 of goodwill. The goodwill impairment is reflected in impairment charge of goodwill and other intangible assets in the Company’s consolidated statements of operations and comprehensive loss for the year ended December 31, 2024. For the year ended December 31, 2025, there were no additions to goodwill.
The following table provides the gross and net carrying value of IPR&D as follows:
The Company completed its impairment test for IPR&D during the fourth quarter of 2024, which resulted in partial impairment of $757 of the Company’s of IPR&D. The IPR&D impairment is reflected in impairment charge of goodwill and other intangible assets in the Company’s consolidated statements of operations and comprehensive loss for the year ended December 31, 2024. The Company completed its quantitative impairment test for IPR&D during the fourth quarter of 2025, and noted the fair value exceeded the carrying value. Consequently, the Company did not record an IPR&D impairment charge during the year ended December 31, 2025.
|
||||||||||||||||||||||||||||||||||||||||||||||||||